Detlef Klaus Bartsch, Marburg, Germany
Discipline
Surgery
Institution
Dept. Visceral-, Thoracic- and Vascular Surgery Philipps-University Marburg
Position
Chairman
Main Interest
- Surgery of small intestine NEN and pNEN
- Surgery of anaplastic thyroid cancer
Tessa Brabander, Rotterdam, The Netherlands
Discipline
Nuclear Medicine
Institution
Erasmus MC
Position
Nuclear Medicine Physician
Main Interest
- Peptide receptor radionuclide therapy
- Functional imaging
Jérôme Cros, Paris, France
Discipline
Pathology
Institution
Université Paris Cité - Hôpital Beaujon
Position
Professor
Main Interest
- Neuroendocrine tumor molecular heterogeneity
- Biomarkers
Meredith Cummins, Sydney, Australia
Discipline
Patient representative
Institution
NeuroEndocrine Cancer Australia
Position
CEO
Main Interest
- Ensure education and awareness of NETs by HCPs is increased
- Ongoing research is available in all countries especially Australia
Gitte Dam, Aarhus, Denmark
Discipline
Gastroenterology
Institution
Aarhus University Hospital
Position
Consultant & ENETS CoE Lead
Main Interest
- PRRT
- Carcinoid heart disease
- Lung NET
Louis de Mestier, Clichy, France
Discipline
Gastroenterology
Institution
Beaujon Hospital, Université Paris-Cité, Clichy
Position
Full Professor
Main Interest
- Predictive and theranostic biomarkers in neuroendocrine tumors
- Clinicopathological and molecular characterization of tumor heterogeneity in neuroendocrine tumors
- Inherited predispositions to digestive neuroendocrine tumors
Clarisse Dromain, Lausanne, Switzerland
Discipline
Radiology
Institution
Lausanne University Hospital and University of Lausanne
Position
Professor
Main Interest
- Gastrointestinal, in particular endocrine and peritoneal tumor imaging
Nicola Fazio, Milan, Italy
Discipline
Oncology
Institution
European Institute of Oncology
Position
Director of Division
Main Interest
- Neuroendocrine neoplasms
- Upper GI cancers
- Hepato-pancreato-biliary cancers
Rocio Garcia-Carbonero, Madrid, Spain
Discipline
Oncology
Institution
Hospital Universitario 12 de Octubre, Universidad Complutense of Madrid
Position
Head, GI and NE Oncology Unit, Oncology Department, Associate Professor
Main Interest
- New drug development in NETs and NECs
- Development of biomarkers in NENs
- Translational research
Simona Glasberg, Jerusalem, Israel
Discipline
Endocrinology
Institution
Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem
Position
Professor
Main Interest
- Enhancers and neuroendocrine neoplasms
- Modulation of endocannabinoid system in neuroendocrine neoplasms
- Theranostic in neuroendocrine neoplasms
Gregory Kaltsas, Athens, Greece
Discipline
Endocrinology
Institution
National and Kapodistrian University of Athens, Dept. of Pathophysiology
Position
Professor
Main Interest
- Inherited Endocrine Syndromes
- Appendiceal neuroendocrien neoplasms
- Gastric Neuroendocrine neoplasms
Andreas Kjaer, Copenhagen, Denmark
Discipline
Nuclear Medicine
Institution
Rigshospitalet & University of Copenhagen
Position
Professor, chief physician
Main Interest
- Molecular imaging of neuroendocrine Tumors
- Theranostics and targeted radionuclide therapy in NET
Beata Kos-Kudła, Katowice, Poland
Discipline
Endocrinology
Institution
Medical University of Silesia, Dept. of Endocrinology and Neuroendocrine Tumors
Position
Professor, Chair of the Department
Main Interest
- Biomarkers in NET
- Diagnosis and treatment of GEP NET
- Lung NET
Anna La Salvia, Rome, Italy
Discipline
Oncology
Institution
National Institute of Health, National Center for Drug Research and Evaluation, Rome
Position
Medical oncologist and researcher
Main Interest
- Biomarkers in NENs
- Lung NENs
- Clinical Trials Evaluation & Regulatory Science
Hannes Leupe, Leuven, Belgium
Discipline
Nuclear medicine
Institution
University Hospitals Leuven
Position
Nuclear medicine resident and PhD candidate
Main Interest
- Somatostatin receptor (SSTR) PET/CT imaging in NETs, with particular expertise in [¹⁸F]AlF-NOTA-octreotide as an alternative to [⁶⁸Ga]Ga-DOTA-SSA tracers
Tu Vinh Luong, London, United Kingdom
Discipline
Cellular Pathology
Institution
Royal Free London NHS Foundation Trust
Position
Consultant Histopathologist, Honorary Associate Professor UCL-ILDH
Main Interest
- Fibrosis in neoplastic and non-neoplastic diseases of the liver, pancreatobiliary system, and small bowel, with a particular focus on mesenteric fibrosis in small bowel NETs
- Development and application of artificial intelligence and digital pathology in diagnostic pathology and research
Mairéad McNamara, Manchester, United Kingdom
Discipline
Oncology
Institution
University of Manchester/The Christie, Manchester, UK
Position
Senior Lecturer/Honorary Consultant & ENETS CoE Lead
Main Interest
- CI for NET-02: A randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma
- Clinical supervisor for PhD: Dissecting the neuroendocrine landscape of extra-pulmonary neuroendocrine carcinoma to discover biomarkers with clinical Utility
- Methylation analysis of samples from NET-02
Francesco Panzuto, Rome, Italy
Discipline
Gastroenterology
Institution
Sant'Andrea University Hospital, Rome, Italy
Position
Associate Professor of Gastroenterology, Sapienza University of Rome, Digestive Disease Unit, Coordinator ENETS CoE of Rome (Sant'Andrea site)
Main Interest
- Gastric Neuroendocrine Neoplasia
- NEN epidemiology (national registry - database)
- Prognostic features and risk factros for NEN progression
Raj Srirajaskanthan, London, United Kingdom
Discipline
Gastroenterology
Institution
Kings College Hospital London
Position
Consultant Gastroenterologist
Main Interest
- Epidemiology and prognosis of Neuroendocrine Neoplasms
- Endoscopic characterisation of resection of NETs
- Ex-vivo models of NETs
Timon Vandamme, Antwerp, Belgium
Discipline
Oncology
Institution
University Hospital Antwerp
Position
Senior Consultant - Assistant Professor
Main Interest
- Circulating cell-free DNA
- Cellular therapies including mRNA vaccinatie, CAR-T and CAR-NK
- (Epi)genomics